methyleugenol has been researched along with nevadensin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Subeihi, AA; Alhusainy, W; Paini, A; Punt, A; Rietjens, IM; van Bladeren, PJ; Vervoort, J | 1 |
Adams, TB; Alhusainy, W; Iatropoulos, MJ; Jeffrey, AM; Rietjens, IM; Taylor, S; Williams, GM | 1 |
2 other study(ies) available for methyleugenol and nevadensin
Article | Year |
---|---|
Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
Topics: Animals; Anticarcinogenic Agents; Biotransformation; Carcinogens; DNA Adducts; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eugenol; Female; Flavones; Hep G2 Cells; Hepatocytes; Humans; Male; Models, Biological; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Risk Assessment; Sulfotransferases; Tissue Distribution | 2013 |
The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat.
Topics: Animals; Body Weight; Carcinogens; DNA Adducts; Eugenol; Flavones; Liver; Liver Neoplasms; Male; Organ Size; Rats; Rats, Inbred F344 | 2014 |